Canary Speech has been named one of the World's Top HealthTech Companies for 2026 by TIME, highlighting its advancements in vocal biomarker technology.

Discover how the partnership between NeuroLexIQ and Canary Speech is enhancing the personal injury intake process through AI voice analysis.

Canary Speech has launched Canary Ambient™ on the Zoom App Marketplace, providing users with real-time vocal analysis for better telehealth outcomes.

Canary Speech has introduced a free voice-based check-in to identify early signs of mental health decline, promising to aid awareness and proactive care.

Canary Speech has made a groundbreaking entry into the consumer health market by collaborating with JubileeTV. This partnership aims to enhance caregiving at home using AI-driven speech analysis.

Canary Speech has earned Frost & Sullivan's 2025 Technology Innovation Leadership honor for its groundbreaking contributions in vocal biomarker technology, marking a significant milestone in healthcare innovation.

Canary Speech has launched its innovative Canary Ambient™ Continuous Monitoring system to enhance safety through real-time aggression detection in healthcare settings.

Canary Speech, a trailblazer in AI-driven voice biomarker technology, earns its place in TIME's inaugural World's Top HealthTech Companies 2025 list, celebrating innovation in healthcare.

Canary Speech has appointed Dr. Kang Hsu, Jr. as its new Chief Medical Officer to lead clinical strategies and enhance the adoption of voice biomarker technology.

Canary Speech has earned HITRUST e1 Certification, showcasing its dedication to strong cybersecurity measures and risk management in health tech.

Discover how Canary Speech is collaborating with Microsoft to enhance healthcare solutions through vocal biomarker technology at HIMSS.

Canary Speech is making waves at HIMSS by partnering with Microsoft, showcasing their pioneering vocal biomarker technology aimed at transforming mental health management.